The Impact of Polycystic Ovary Syndrome on the Sporting Performance of Female Players


  • Bilal Ahmad Department of Sports Sciences and Physical Education, The University of Lahore, Lahore, Pakistan
  • Syeda Maryam Zahra Lahore College for Women University, Lahore, Pakistan



Polycystic Ovary Syndrome (PCOS) is perhaps the most widely recognized endocrine issues in females of reproductive age, influencing up to 20% of individuals of this populace. Many recent studies indicate that testosterone, which can increase muscle mass and strength, stimulates erythropoiesis, promotes competitive behavior, and enhances sporting performance of female athletes. Methods: The comparative study was designed and conducted in which a sample of female athletes (n=40) who had been diagnosed with PCOS by a qualified gynecologist based on clinical features and lab tests. At the same time, a healthy group of female athletes (n=40) was selected from participants of the same population and having regular menses and showing no clinical features of PCOS. The main objectives of the study included: 1) to compare both the groups of female athletes on clinical features of PCOS, and 2) to compare both the groups on self-perceived sports performance. Data was collected from The University of Central Punjab, The University of Lahore, and The University of Lahore College for Women. Data collection was done using two different instruments involving “Polycystic Ovary Syndrome Questionnaire (PCOSQ)” and “Athlete’s Subjective Performance Scale (ASPS)”. Data analyses involved descriptive analysis followed by “Independent Sample t test’ to compare the physical and psychological impact of PCOS and ANOVA was applied to analyze the impact of PCOS on sports performance. Results: There were significant differences between female athletes with PCOS and those with Non-PCOS on physical and psychological conditions. Weight issues t (78) =15.104, (p= .000), Body Hair t (78) =25.108, (p= .000), Menstrual Problems t (78) =20.976, (p= .000), Helplessness t (78) =17.775, (p= .000), and Low mood t (78) =8.449, (p= .000). Significance value (p = .000), which is below 0.05 and, therefore, there is a statistically significant difference in the mean sporting performance. Conclusion: Based on the results, it can be concluded that female athletes with PCOS were more concerned about their physical and psychological conditions. Moreover, their sporting performance was statistically significantly higher than Non-PCOS athletes, which is attributed to higher energy level caused by PCOS itself. Future research must focus on measuring energy level of female athletes with PCOS and Non-PCOS.


Hossein KJ, Leila KJ, Ebrahim TK, Nazanin SJ, Farzad P and Elham R et al. The Effect of Pomegranate Juice Extract

on Hormonal Changes of Female Wistar Rats Caused by Polycystic Ovarian Syndrome. Biomed Pharmacol J.


Unluturk U, Harmanci A, Kocaefe C and Yildiz BO. The Genetic Basis of the Polycystic Ovary Syndrome: A Literature

Review Including Discussion of PPAR-gamma. PPAR Res. 2007;2007:49109. doi: 10.1155/2007/49109.

Mutharasan P, Galdones E, Peñalver Bernabé B, Garcia OA, Jafari N and Shea LD et al. Evidence for chromosome

p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocrinol

Metab. 2013;98(1):E185-90. doi: 10.1210/jc.2012-2471.

Melin AK, Heikura IA, Tenforde A and Mountjoy M. Energy Availability in Athletics: Health, Performance, and

Physique. Int J Sport Nutr Exerc Metab. 2019;29(2):152-164. doi: 10.1123/ijsnem.2018-0201.

Costello JT, Bieuzen F and Bleakley CM. Where are all the female participants in Sports and Exercise Medicine

research? Eur J Sport Sci. 2014;14(8):847-51. doi: 10.1080/17461391.2014.911354.

Gur EB, Karadeniz M and Turan GA. Fetal programming of polycystic ovary syndrome. World J Diabetes.

;6(7):936-942. doi:10.4239/wjd.v6.i7.936.

Makieva S, Saunders PT and Norman JE. Androgens in pregnancy: roles in parturition. Human Reproduction Update.


Lindholm C, Hirschberg AL, Carlström K and von Schoultz B. Altered adrenal steroid metabolism underlying

hypercortisolism in female endurance athletes. Fertil Steril. 1995;63(6):1190-4.

Witchel SF, Oberfield SE and Peña AS. Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment

With Emphasis on Adolescent Girls. J Endocr Soc. 2019;3(8):1545-1573. Published 2019 Jun 14. doi:10.1210/js.2019-

Loucks AB, Verdun M and Heath EM. Low energy availability, not stress of exercise, alters LH pulsatility in exercising

women. J Appl Physiol (1985). 1998;84(1):37-46. doi: 10.1152/jappl.1998.84.1.37.

Saadia Z. Follicle Stimulating Hormone (LH: FSH) Ratio in Polycystic Ovary Syndrome (PCOS) - Obese vs. NonObese Women. Med Arch. 2020;74(4):289-293. doi: 10.5455/medarh.2020.74.289-293.

Hajimonfarednejad M, Nimrouzi M, Heydari M, Zarshenas MM, Raee MJ and Jahromi BN. Insulin resistance

improvement by cinnamon powder in polycystic ovary syndrome: A randomized double-blind placebo controlled

clinical trial. Phytother Res. 2018;32(2):276-283. doi: 10.1002/ptr.5970.

Arena B, Maffulli N, Maffulli F and Morleo MA. Reproductive hormones and menstrual changes with exercise in

female athletes. Sports Med. 1995;19(4):278-87. doi: 10.2165/00007256-199519040-00005.

Najem Fi, Elmehdawi Rafik and Swalem Am. Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome

in Benghazi- Libya: A Retrospective Study. The Libyan journal of medicine. 2008;3:71-4. DOI:10.4176/080122.

Banfi G and Dolci A. Free Testosterone/cortisol Ratio in Soccer: Usefulness of a Categorization of Values. J Sports

Med Phys Fitness. 2006;46(4):611–16.

Hardy T, De Sousa S and Norman RJ. Polycystic ovary syndrome: prognosis and risk of comorbidity. In Novel insights

into the pathophysiology and treatment of PCOS. 2013:122-134.

Mario FM, do Amarante F, Toscani MK and Spritzer PM. Lean muscle mass in classic or ovulatory PCOS: association

with central obesity and insulin resistance. Exp Clin Endocrinol Diabetes. 2012;120(9):511-6. doi: 10.1055/s-0032-

Carmina E, Guastella E, Longo RA, Rini GB and Lobo RA. Correlates of increased lean muscle mass in women with

polycystic ovary syndrome. Eur J Endocrinol. 2009;161(4):583-9. doi: 10.1530/EJE-09-0398.

Wood RI and Stanton SJ. Testosterone and sport: current perspectives. Horm Behav. 2012;61(1):147-155.


Arngrímsson SA, Petitt DS, Borrani F, Skinner KA and Cureton KJ. Hyperthermia and maximal oxygen uptake in men

and women. Eur J Appl Physiol. 2004;92(4-5):524-32. doi: 10.1007/s00421-004-1053-1.

Handelsman DJ, Hirschberg AL and Bermon S. Circulating Testosterone as the Hormonal Basis of Sex Differences in

Athletic Performance. Endocr Rev. 2018;39(5):803-829. doi: 10.1210/er.2018-00020.



DOI: 10.54393/tt.v1i2.22
Published: 2020-12-31

How to Cite

Ahmad, B., & Zahra, S. M. . (2020). The Impact of Polycystic Ovary Syndrome on the Sporting Performance of Female Players. THE THERAPIST (Journal of Therapies &Amp; Rehabilitation Sciences), 1(2), 26–30.



Original Article